
Supreme Court Keeps Mail-Order Abortion Pill Access Intact
In a shadow-docket ruling, the Supreme Court blocked the Fifth Circuit’s attempt to ban mail-order mifepristone, keeping nationwide access available for now as Louisiana’s challenge moves back to the Fifth Circuit. The 7-2 decision, with Justices Thomas and Alito dissenting, highlights ongoing clashes between state abortion restrictions, federal drug regulation, and the Comstock Act, while the FDA continues its safety review of mifepristone and the case awaits further appellate action.


